India

Natco Pharma, 3 other pharma stocks decline up to 2.5% after important inspections at their units. Do you own?

Indian pharmaceutical stocks, including Lupin, Shilpa Medicare, and Natco Pharma, are under scrutiny following recent USFDA inspections at their manufacturing sites. These audits yielded regulatory observations, prompting companies to address the findings. Alkem Laboratories, however, reported no critical issues from a separate Armenian health ministry audit at its Sikkim facility. Source link

India

Negative Breakout: These 8 stocks cross below their 200 DMAs

In the Nifty200 pack, 8 stocks’ close prices crossed below their 200 DMA (Daily Moving Averages) on November 21, according to stockedge.com’s technical scan data. Trading below the 200 DMA is considered a negative signal because it indicates that the stock’s price is below its long-term trend line. The 200 DMA is used as a key indicator by traders for determining the overall trend in a particular stock. Take a look: Source link